Generic Name (S): oxybutynin chloride
Food and Drug Administration (FDA) and is indicated for patients with overactive bladder or symptoms of detrusor overactivity, such as
Oxybutynin (Oral Route) Precautions
Oxybutynin: Uses, Interactions
1
Exclusive private estate for rent MAS TORROELLA This grand 14th Century Catalan manor house offers a unique opportunity to experience elegance, luxury and tradition in a
Oxybutynin chloride extended-release tablets must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed
Tablets, USP 5 mg Oxybutynin Chloride Extended-Release Tablets, USP 5 mg
Some common side effects of oxybutynin include dry mouth, constipation, and dizziness
Serious side effects of Oxybutynin
The NDC code 68382-255 is assigned by the FDA to the product Oxybutynin which is a human prescription drug product labeled by Zydus Pharmaceuticals Usa Inc
Oxybutynin Chloride Tablets, USP also contain FD&C Blue # 1/Brilliant Blue FCF aluminum lake, lactose anhydrous, magnesium stearate, microcrystalline cellulose and sodium starch
It comes in 2 strengths: 2
Oxybutynin chloride extended-release tablets USP, 10 mg are white to off-white, round, beveled-edged, biconvex, coated-tablets debossed on one side with "256"
Follow the directions on your prescription Oxybutynin chloride extended-release tablets USP, 5 mg are white to off-white, round, beveled-edged, biconvex, coated-tablets debossed on one side with "255" and plain on other side
Dry mouth, dizziness, drowsiness, blurred vision, dry eyes, nausea, vomiting, upset stomach, stomach pain, constipation, diarrhea, headache, unusual taste in mouth, dry/flushed skin Oxybutynin chloride extended-release tablets USP, 5 mg are white to off-white, round, beveled-edged, biconvex, coated-tablets debossed on one side with "255" and plain on other side
finerenone
slide 32 of 34 Pharmacokinetics
WHITE ROUND Pill with imprint 256 tablet, film coated, extended release for treatment of Urinary Bladder, Neurogenic, Colitis, Ulcerative, Intestinal Obstruction, Megacolon, Toxic, Myasthenia Gravis, Ureteral Obstruction, Urinary Incontinence, Glaucoma, Angle-Closure, Urinary Retention, Gastroparesis, Dysuria, Glaucoma with Adverse Reactions & Drug
Distributed by: Zydus Pharmaceuticals (USA) Inc